Jiangsu CoWin Biotech Co., Ltd. (SHSE: 688426)
Health Care · Biotechnology · CN
CN¥22.58
+2.82% today · -19.2% 1Y
Jiangsu CoWin Biotech Co., Ltd. (SHSE: 688426) operates in the Biotechnology industry within the Health Care sector. The company is valued at $370.06M.
Over the last twelve months the share price has lost 19.2%, trading between 14.42 and 33.67.
Tweenvest scores Jiangsu CoWin Biotech Co., Ltd. across four factors: quality 58/100, value 83/100, growth 100/100. Its strongest factor is growth.
688426 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $370.06M
- Revenue (TTM)
- $32.30M
- P/E
- —
- EPS
- -0.79
- Dividend yield
- —
- Beta (5Y)
- 0.77
- 52-week high
- CN¥33.67
- 52-week low
- CN¥14.42
- Avg volume (3M)
- —
- Shares outstanding
- 109.93M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Prelude Therapeutics IncorporatedNasdaqGS: PRLD | $377.99M | $3.83 | +4.36% |
| Heartseed Inc.TSE: 219A | $374.34M | ¥2,579.00 | -4.38% |
| Formycon AGXTRA: FYB | $373.83M | €18.90 | -0.21% |
| Arcturus Therapeutics Holdings Inc.NasdaqGM: ARCT | $370.35M | $12.77 | -2.03% |
| Opus Genetics, Inc.NasdaqCM: IRD | $366.89M | $4.41 | +0.68% |
| BioDlink International Company LimitedSEHK: 1875 | $366.35M | HK$3.72 | -3.38% |
| Inhibikase Therapeutics, Inc.NasdaqCM: IKT | $364.15M | $1.94 | -3.00% |
| Emergent BioSolutions Inc.NYSE: EBS | $362.50M | $7.07 | +1.73% |
Figures last refreshed Oct 4, 2026.